some attractive biological characteristics as a drug target. First, its site of action within the central death machinery may provide a target for specific inhibition of cell death. Second, its low basal levels in most tissues may minimize the possibility of untoward effects in nontarget organs. Third, the fact that Bnip3 is induced in response to hypoxia suggests that there is a temporal window, prior to significant Bnip3 accumulation and cell death, during which treatment could be beneficially instituted. Despite these characteristics, significant logistical hurdles exist in designing a practical pharmacological approach to inhibit this intracellular protein. The prevalence of both obesity and type 2 diabetes are increasing at an alarming rate. Clearly, an improved understanding of the mechanisms involved in energy homeostasis will be required to halt these epidemics. In 1994, the cloning of the peptide hormone leptin, an adipocyte-derived factor secreted in proportion to body fat, opened new doors for exploring the molecular mechanisms underpinning energy homeostasis (1). However, despite an avalanche of new knowledge gained since then, many fundamental questions remain unanswered, including how systems regulating energy homeostasis interface with those that regulate glucose homeostasis.
Leptin and glucose homeostasis
Mice and humans that are deficient in either leptin (in the case of ob/ob mice) or the leptin receptor (db/db mice) not only develop obesity, but become both insulin resistant and glucose intolerant and are at high risk to develop diabetes (1-3). The pro-found insulin resistance and glucose intolerance that characterize leptin deficiency are, intriguingly, to some degree independent of body weight. Indeed, treatment of leptin-deficient animals with leptin restores glucose homeostasis independent of weight loss (4) , which suggests that leptin may act directly on pancreatic β cells to affect their function. Toward that end, in this issue of the JCI, Morioka and coworkers describe a pancreas-wide knockout of the leptin receptor in mice (5) . Interestingly, the principal phenotype of their mice, namely improved glucose tolerance, is in apparent contradiction to that reported in a recent study by Covey et al. (6) , who also utilized a Cre-loxP strategy to assess the effect of a combined β cell and partial hypothalamic knockout of the leptin receptor. Covey et al. concluded that the loss of leptin signaling in the pancreatic β cell causes impaired β cell function, although their animals, like those studied by Morioka et al., exhibited fasting hypoglycemia relative to the controls due to insulin hypersecretion.
Weighty differences in experimental design and outcome
To attempt to reconcile these two very similar studies, it is vital to have an understanding of the biology of both the floxed leptin receptor alleles and the Cre recombinase driver mice that were used. Morioka et al. (5) used a conditional allele that removes exon 1 from the leptin receptor gene (7), whereas that used by Covey et al. (6) removes exon 17 (8) . Cre recombinase causes a total gene ablation of the former allele, whereas a frameshift mutation of the leptin receptor occurs in the latter situation, resulting in a receptor protein that lacks both Tyr985 and Tyr1138 - sites of JAK-mediated phosphorylation necessary for leptin-stimulated STAT phosphorylation (8) . While total gene ablations of proteins that provide scaffolding functions may sometimes generate misleading phenotypes, this is unlikely to be the case here. Rather, the different phenotypes observed are far more likely to be due to the use of different Cre driver lines, which led to the absence of the leptin receptor in overlapping but different cell types and tissues. Although the Cre driver lines used by both groups are state of the art, in neither case does the gene deletion occur only in pancreatic β cells.
Covey et al. (6) used the well-known rat insulin 2 promoter (RIP) Cre driver line (9) to generate a combined β cell and partial mediobasal hypothalamic knockout of the leptin receptor. On the other hand, Morioka et al. (5) used a pancreatic and duodenal homeobox 1-Cre (Pdx1-Cre) transgene to disrupt expression of the leptin receptor in the pancreas without affecting its expression in the brain. However, it should be noted that Pdx1 is broadly expressed in the posterior foregut during development (10) (11) (12) . Thus, the use of a Pdx1-Cre transgene by Morioka et al. may have also deleted expression of the leptin receptor in cells that secrete glucagon, glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic peptide (GIP), ghrelin, and others, all of which have well-known roles in glucose homeostasis. Nonetheless, even if leptin signaling was disrupted in other cell types, the findings are almost certainly due to changes in β cell function. Comparison of the two studies suggests that deletion of the leptin receptor in the hypothalamus of the mice utilized by Covey et al. (6) is a more significant factor than initially thought. While these investigators reasonably attempted to control for this possibility by comparing β cell function in weightmatched animals, an experiment performed by Morioka et al. (5) becomes key for reconciling the observed phenotypic differences. They tested the effect of a high-fat diet on mice lacking leptin receptors only in the pancreas and found that as the mice developed diet-induced obesity, the phenotype of these animals shifted from one of improved to impaired β cell function, relative to that of mice that had intact leptin receptors
Figure 1
Effects of leptin on the pancreatic β cell. The secretion of insulin is a complex, multistep process. The β cell senses nutrient availability, including that of glucose, amino acids, and fatty acids, through the metabolism of these molecules. An increase in the ATP/ADP ratio stimulates closure of the KATP channel, thereby causing depolarization of the plasma membrane, activation of a voltage-dependent calcium channel, and insulin exocytosis. The study by Morioka et al. (5) in this issue of the JCI shows that, in the context of overnutrition, leptin attenuates insulin secretion by the β cell. First, leptin appears to function to maintain the patency of the KATP channel, thereby hyperpolarizing the β cell plasma membrane. This could occur either by enhancing channel activity or by rendering the channel less sensitive to changes in the ATP/ADP ratio. Second, leptin may play a role in maintaining flux through key metabolic pathways of intermediary metabolism by assuring the proper allosteric and transcriptional regulation of key metabolic enzymes. If so, impaired leptin signaling in the β cell could lead to an enhanced susceptibility to the negative effects of overnutrition, thereby causing an impairment of insulin secretion.
in their β cells. Thus, it now appears that because the genetically engineered mice made by Covey et al. were heavier than littermate controls, they exhibited impaired β cell function. Therefore, given the model proposed below, obese animals that lack leptin signaling in their β cells will have decreased β cell function, compared with weight-matched controls. Covey et al. (6) simply achieved obesity through a genetically induced impairment of leptin signaling in the hypothalamus instead of by feeding a high-fat diet, as did Morioka et al. (5) .
The pancreatic β cell and metabolic sensing
The pancreatic β cell is an exquisite metabolic energy sensor. Although glucose is the principal insulin secretagogue, amino acids, fatty acids, and a number of hormones (including both insulin and leptin) and neurotransmitters also affect the amount of insulin that is secreted (Figure 1) . The intracellular mechanisms that couple these various stimuli to insulin secretion are both complex and highly interdependent. For instance, the ATP-sensitive potassium (K ATP ) channel, which determines β cell membrane potential, also serves to couple intracellular metabolism to plasma membrane potential in the β cell. This channel is sensitive to changes in the ATP/ADP ratio, PI3K signaling (mediated either by insulin [ref. 13] or leptin [ref. 14]), and long-chain fatty acids or their derivatives (15, 16) . Closure of this channel leads to membrane depolarization, activation of a voltage-dependent calcium channel, influx of calcium, and the initiation of insulin secretion.
Leptin induces β cell hyperpolarization by activating insulin-like signal transduction - a phenomenon referred to as cross-talk (17) - which, by activating the K ATP channel, inhibits insulin secretion. Cross-talk between leptin and insulin signaling is a more complex process than it may first appear, especially given a number of recent findings (14, 18) . Nonetheless, the absence of leptin signaling in β cells of lean mice is predicted to improve basal insulin secretion by removing this hyperpolarizing force. While this prediction is confirmed by the findings of both groups (5, 6), the K ATP channel-dependent membrane effects of leptin are not the end of the story (Figure 1) .
As we now know, consumption of a highfat diet, or overnutrition, in either humans or rodents causes metabolic alterations that increase the risk of developing diabetes. Many different names have been coined to describe these alterations (e.g., insulin resistance, glucotoxicity, lipotoxicity, oxidative stress, and mitochondrial dysfunction). Whatever term one prefers, nutrient excess leads to an uncoupling of the sensory secretion mechanisms in the β cell. Intermediary metabolism serves as the vital link by enabling the β cell to sum and integrate a plethora of different metabolic stimuli. For example, glucose oxidation, fatty acid oxidation, and long-chain fatty acyl CoA synthesis are so interlinked that they oscillate in synchrony (19) . Inhibition of key control steps in these signaling pathways, as occurs in the setting of overnutrition, impairs insulin secretion. It has long been thought that a vital function of leptin at the cellular level is to maintain the ebb and flow of cellular metabolic information by preventing the accumulation of fat in the wrong places, such as β cells, where it leads to cellular dysfunction (20) . The findings of both Morioka et al. (5) (6) support a role for leptin signaling in the pancreatic β cell, they also have broader implications for understanding energy homeostasis. Since (a) leptin is secreted in direct proportion to adipose mass; (b) insulin is potently lipogenic; and (c) leptin has a restraining effect on the β cell, the new findings validate the existence of an adipose tissue-islet feedback loop in which insulin secretion by the β cell is inversely related to body fat ( Figure 2) . Moreover, these findings add additional complexity to current models of energy homeostasis that will require further exploration and validation. Indeed, it is becoming clear that one must conceptualize energy homeostasis in a very broad manner that simultaneously considers the effects of glucose, insulin, and leptin in multiple tissues.
Finally, these findings also highlight several long-standing questions, such as, why doesn't obesity always cause diabetes? For any biological system this important and complex, there will certainly be other physiological mediators whose function is to further integrate the signals generated principally by glucose, insulin, and leptin. However, to understand what these mediators are and how they work, the use
Figure 2
Homeostatic feedback loops affecting energy homeostasis and glucose homeostasis. Leptin and insulin are both secreted in proportion to energy availability. Whereas leptin secretion is indicative of adipose mass and thus is more chronic in nature, insulin secretion reflects both acute and chronic nutritional status. The findings of Morioka et al. (5) validate the existence of an adipose tissue-islet endocrine feedback loop. Insulin is both potently lipogenic and functions in the CNS to reduce nutrient intake. Leptin also acts on the CNS to reduce nutrient intake and directly on β cells in lean animals to inhibit insulin secretion. The findings of both Morioka et al. (5) and Covey et al. (6) suggest that as body weight increases, leptin signaling protects the β cell from the adverse effects of overnutrition. Thus, glucose and energy homeostasis should both be considered in a very broad manner that simultaneously takes into account the effects of glucose, insulin, and leptin in multiple tissues.
of Cre-expressing mice that express this enzyme in a strictly β cell-specific manner will be essential. Indeed, considering that efforts are currently underway to generate conditional alleles for virtually all genes, the Cre-loxP strategy will be a cornerstone technology for understanding energy homeostasis in the mouse. However, certain lines of mice, including the B6.Cg-Tg(Ins2-Cre)25Mgn/J animals we generated nearly ten years ago (9) and that were used by Covey et al., need to be supplemented by more robust models that are free of some of the flaws that have been so aptly demonstrated here and elsewhere.
